Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.
about
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyEnigma (partially) resolved: phospholipase A2 receptor is the cause of "idiopathic" membranous glomerulonephritisTranslational nephrology: what translational research is and a bird's-eye view on translational research in nephrologyAnti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPharmacological treatment of primary membranous nephropathy in 2016.Changing the concepts of immune-mediated glomerular diseases through proteomics.THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivityPregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case ReportEpitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.Membranous Nephropathy: A Journey From Bench to BedsideClinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.Phospholipase A2 Receptor Gene Polymorphisms Alter its Functions and Present a Genetic Risk of an Increased Intima-Media Thickness of the Carotid Artery.Biomarkers to detect membranous nephropathy in Chinese patients.Designing drugs that combat kidney damage.Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy.Immunology of membranous nephropathy: from animal models to humans.Primary Membranous Nephropathy.Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.Membranous nephropathy in the kidney allograft.Blocking peptides and molecular mimicry as treatment for kidney disease.New Insights into Podocyte Biology in Glomerular Health and Disease.Membranous nephropathy-one morphologic pattern with different diseases.Treatment of membranous nephropathy: time for a paradigm shift.PLA2R and THSD7A: Disparate Paths to the Same Disease?PLA2R binds to the annexin A2-S100A10 complex in human podocytes.Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous NephropathyAnti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy.Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π.Immune Response against Autoantigen PLA2R Is not Gambling: Implications for Pathophysiology, Prognosis, and Therapy.Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.Genetics of membranous nephropathy.Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency.Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.A New Classification System for IgG4 Autoantibodies.Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
P2860
Q27023372-DA689D78-654D-405C-8ED6-767992B53B55Q28083035-8E3F7886-FB4B-46B0-B786-E6DAFCA61DE1Q35026517-A98DB36A-47BB-4F9A-880C-676F3978AD58Q36104805-6FA9D32A-606E-4B14-8E60-EC9BAE3F7A6FQ36106413-7A7363EA-E6BA-4C73-825C-8C2A6911A563Q36201993-8DED2D9B-47B5-4F5B-B70F-ABA96428F780Q36764775-74B7E44A-9137-438C-86A3-FF19121AAD23Q36814021-ED7253C6-B5C1-4ABE-BD6F-BCA41A403531Q36849177-263F5D17-F25B-4FE0-88E3-72E2C2D730F8Q37038576-DB7280ED-F291-421D-A636-812B023D3FB7Q37328402-E6F8B066-C737-4B11-9402-ADCE30FA8D05Q37398564-C8C15301-DD69-46DB-AB5A-94B08345A364Q37708722-F11CB014-D3FC-42D4-9575-ED6B0CC1E0FBQ38404587-9B18D8CF-17CA-402A-97F9-0B210A073076Q38602846-ADAB83F1-50A5-4B9C-80F7-5C78A9EC6A62Q38605469-798E82E0-3183-4624-9473-958207643119Q38760741-ADAED785-5864-4364-B10A-995EA53EEBB1Q38874091-51ED6DDE-80F1-4FB5-8C41-ACF9EB144016Q38959093-EF80FF00-7C57-4D13-8568-506EC52263B0Q38961136-7B5583D0-7ED8-4D74-9D09-46144EFAF7A4Q39238888-8AB9C751-735B-4006-B734-F7B96A85B0A5Q39337229-01DEC0AF-2D2B-4168-AEA4-03785BF1A146Q39410091-5086477B-A7C1-4CCB-B942-33E014FF0987Q39412533-E103F2F1-8CE4-4F1C-A163-E6083B3C07BCQ41191481-88A01E55-7C7F-4C47-88E1-6CCA2151C607Q41622450-B87080CE-865D-4118-85FA-2D967FC9DA76Q41645471-44D37BCF-F56C-4F67-BA25-A6E6671B0267Q42286490-C8946555-A3C1-4B5E-B050-160992FA109EQ42535148-61F8152A-5DFC-4760-8646-C90F84D8F98BQ42554767-E99BBEE2-7295-4F11-B4EC-A018F02298D1Q42849501-43460455-DF92-4FE0-9FD4-ED0E20BB23CEQ43236774-D7AE10FD-DB2C-4B90-AD3C-0C56CDA1889EQ46459379-FE4705BB-DF77-43E9-9453-DCBB79260B7DQ47846250-96D2D595-5914-4D09-804B-354DB36E912AQ49362025-23457C84-A78A-48A0-B00C-11C15F593A6CQ50116914-C5DB184A-9E7B-4F37-BCDD-BCDBBBED9FE1Q50327901-27757E2C-CEE4-47C7-A3A5-8485DB4904BFQ50908320-F14D0445-44D2-4A96-B25E-1F638F4CE0D1Q52349819-44291440-9445-4B2A-B8B6-C40D0BA1350DQ52670774-9D1A6D51-7B8E-4746-82D4-B89F32C5BCB5
P2860
Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Identification of a major epit ...... rimary membranous nephropathy.
@en
Identification of a major epit ...... rimary membranous nephropathy.
@nl
type
label
Identification of a major epit ...... rimary membranous nephropathy.
@en
Identification of a major epit ...... rimary membranous nephropathy.
@nl
prefLabel
Identification of a major epit ...... rimary membranous nephropathy.
@en
Identification of a major epit ...... rimary membranous nephropathy.
@nl
P2093
P2860
P50
P356
P1476
Identification of a major epit ...... rimary membranous nephropathy.
@en
P2093
Edward A McKenzie
Jennet Gummadova
Richard Collins
Ronan O'Cualain
Thomas A Jowitt
P2860
P304
P356
10.1681/ASN.2014050502
P577
2014-10-06T00:00:00Z